SHWZ News and Press, Medicine Man Technologies Inc. From 09/08/22

Schwazze Announces Grand Opening Of Star Buds Dispensary in City of Glendale Canada NewsWire The Newly Renovated Star Buds Dispensary to Host a Grand Opening September 10, 2022 DENVER , Sept. 8, 2022 /CNW/ - Schwazze (OTCQX: SHWZ) (NEO: SH...

Schwazze is taking a different approach to cannabis than other companies. The latest quarterly report is evidence their unusual strategy is working. It's a good time for risk tolerant investors to start or add to an investment. I first wrote about Schwazze ( OTCQX:SHWZ )...

2Q22 Results. Revenue for the quarter totaled $44.3 million, up from $31.8 million in the first quarter and $30.7 million a year ago. The increase was mostly due to acquisitions as the Colorado market continued to experience softness from the 2021 COVID highs. Adjusted EBITDA was $15.0 million...

Shwazze (OTCQX: SHWZ) posted positive results on Thursday as the company expands in its quest to become a commanding regional MSO. The Colorado-based seed-to-sale operator — formerly known as Medicine Man Technologies — delivered its second-quarter financial repo...

The following slide deck was published by Medicine Man Technologies, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Medicine Man Technologies, Inc. 2022 Q2 - Results - Earnings Call Presentation

Schwazze (SHWZ) Q2 2022 Earnings Conference Call August 11, 2022, 17:00 ET Company Participants Joanne Jobin - IR Justin Dye - Executive Chairman & CEO Nancy Huber - CFO Nirup Krishnamurthy - Director & COO Conference Call Participants P...

DENVER, Aug. 11, 2022 /PRNewswire/ - Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced financial results for the second quarter ended June 30, 2022 ("Q2 2022"). Read More >>

Medicine Man Technologies ( OTCQX:SHWZ ) is scheduled to announce Q2 earnings results on Thursday, August 11th, after market close. The consensus EPS Estimate is -$0.03 (vs. -$0.08 last year) and the consensus Revenue Estimate is $39.55M (+28.7% Y/Y). Over the last 3 month...

Jon DeCourcey shares how his cannabis investing philosophy has shifted over the past few months. Micro vs macro perspective, risk on vs risk off environment. What is going on in Washington? Is there reason for more optimism on political front? Moving pieces of continued cannab...

Banking legislation push is getting a lot of buzz. SAFE passage would be a game changer for valuations with large MSOs disproportionately benefitting with initial stock gains. Within that group, believe Ascend and AYR should be considered for near-term investment. Both are as well...